St-Coeur, Patrick-Denis <br/><br/>
Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.  [electronic resource] 

 -  Genomics, proteomics & bioinformatics  Aug 2013 
 - 199-206 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2210-3244 
<br/><br/><label>Standard No.: </label>10.1016/j.gpb.2013.04.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Dacarbazine--analogs & derivatives<br/>Drug Resistance, Neoplasm<br/>Glioblastoma--drug therapy<br/>Humans<br/>Metabolomics--methods<br/>Prognosis<br/>Temozolomide